Biopharmaceutics Inc. engages Bluelake Capital for acquisition research and negotiations.BELLPORT, N.Y.--(BUSINESS WIRE)---May 14, 1996--Biopharmaceutics Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BOPH BOPH Board of Parole Hearings (Canada; also seen as BPH) ) has engaged Bluelake Capital to research and negotiate possible future acquisitions of product lines and/or corporate entities. According to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. Biopharmaceutics' president, Edward Fine, "Bluelake was instrumental in locating and negotiating our recent acquisition of feminine hygiene Feminine hygiene is a general term used to describe products used by women during menstruation, vaginal discharge, and other bodily functions related to the vulva. Sanitary Towels (also known as maxi-pads or napkins), pantiliners, tampons, and feminine wipes are the major products. We feel that with Bluelake's knowledge of our company, product lines and our marketing and manufacturing capabilities, as well as their knowledge of the markets both here and abroad, Biopharmaceutics will benefit from any transactions Bluelake pursues." Biopharmaceutics Inc. manufactures and markets the Feminine Hygiene Products, Koromex(R), Koroflex(R), Vaginex(R) and Feminique(R), and a line of generic over-the-counter products. CONTACT: Biopharmaceutics Inc., Bellport Stuart Fine, 516/286-5800 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion